30 Day Trial

SI-BONE Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield


Blue Cross and Blue Shield (BCBS) of Illinois, Montana, New Mexico, Oklahoma and Texas have updated coverage policies for minimally invasive sacroiliac joint fusion, maintaining exclusive positive coverage for SI-BONE's iFuse Implant System®. BCBS is the fourth-largest commercial health insurer in the U.S., covering ~15MM lives.

The BCBS policy states that "use of minimally invasive or percutaneous SIJ fusion products other than titanium triangular implants/devices (e.g., iFuse Implant System) is considered experimental, investigational and/or unproven." Thus, all other systems, as they are unproven, are not covered by BCBS. SelectHealth in Utah and Geisinger in Pennsylvania also offer exclusive positive coverage for iFuse.

Sources: SI-BONE, Inc.; BCBS of Illinois